Evidence map›Paper›PMID 31967344›Full record

ArticleDiabetic medicine : a journal of the British Diabetic Association2020

Self-rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE-ON trials.

X Hua, T W C Lung, M Woodward, J A Salomon, P Hamet, S B Harrap, G Mancia, N Poulter, J Chalmers, P M Clarke

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetic medicine : a journal of the British Diabetic Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

X HuaSchool of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.ORCID 0000-0003-2102-5461
T W C LungGeorge Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia.
M WoodwardGeorge Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia.
J A SalomonDepartment of Medicine, Stanford Medical School, Stanford, CA, USA.
P HametCentre de Recherche, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
S B HarrapDepartment of Physiology, University of Melbourne, Melbourne, VIC, Australia.
G ManciaUniversity of Milano-Bicocca, Milan, Italy.
N PoulterImperial Clinical Trials Unit, School of Public Health, Imperial College London, London, UK.
J ChalmersGeorge Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia.
P M ClarkeSchool of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.ORCID 0000-0002-7555-5348

Funding

Australian Research Council CE170100005Health Research Biomedical Research Centre at the University of Oxford NIHR-BRC-1215-20008National Health and Medical Research Council 1079621National Health and Medical Research Council 1080206National Health and Medical Research Council 1084347National Health and Medical Research Council 1141392
6 · The paper itself

Abstract

aimsTo explore whether there is a different strength of association between self-rated health and all-cause mortality in people with type 2 diabetes across three country groupings: nine countries grouped together as 'established market economies'; Asia; and Eastern Europe.

methodsThe ADVANCE trial and its post-trial follow-up were used in this study, which included 11 140 people with type 2 diabetes from 20 countries, with a median follow-up of 9.9 years. Self-rated health was reported on a 0-100 visual analogue scale. Cox proportional hazard models were fitted to estimate the relationship between the visual analogue scale score and all-cause mortality, controlling for a range of demographic and clinical risk factors. Interaction terms were used to assess whether the association between the visual analogue scale score and mortality varied across country groupings.

resultsThe visual analogue scale score had different strengths of association with mortality in the three country groupings. A 10-point increase in visual analogue scale score was associated with a 15% (95% CI 12-18) lower mortality hazard in the established market economies, a 25% (95% CI 21-28) lower hazard in Asia, and an 8% (95% CI 3-13) lower hazard in Eastern Europe.

conclusionsSelf-rated health appears to predict 10-year all-cause mortality for people with type 2 diabetes worldwide, but this relationship varies across groups of countries.

Indexed as

Diabetes Mellitus, Type 2Health StatusMortalityAgedAsiaAustraliaCanadaCause of DeathEurope, EasternFemaleFranceGermanyHumansIrelandItalyMale

Identifiers

PMID31967344
PMCPMC7496988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.